Literature DB >> 403195

Increase in plasma growth hormone levels following thyrotropin-releasing hormone injection in children with primary hypothyroidism.

R Collu, G Leboeuf, J Letarte, J R Ducharme.   

Abstract

Thyrotropin-releasing hormone (TRH) induced a significant increase in plasma growth hormone (GH) levels in 4 of 8 children with primary hypothyroidism, while a slight decrease was observed in 8 control children. Base-line plasma prolactin (PRL) levels and peak responses to TRH were higher in hypothyroid children than in controls. These data may indicate the existence of dysfunction of central nervous system mechanisms of control of GH and PRL secretion in subjects with primary hypothyroidism.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 403195     DOI: 10.1210/jcem-44-4-743

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

1.  The effect of TRH on the release of TSH, PRL and GH in man under basal conditions and following methysergide.

Authors:  R Collu
Journal:  J Endocrinol Invest       Date:  1978-04       Impact factor: 4.256

2.  Effects of intravenous TRH on growth hormone and cortisol serum levels in children and adolescents with insulin dependent diabetes mellitus.

Authors:  M Vanelli; S Bernasconi; O Bolondi; C Mamì; E Pandullo; M Scaffidi; M F Siracusano; F De Luca
Journal:  J Endocrinol Invest       Date:  1986-08       Impact factor: 4.256

Review 3.  Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin.

Authors:  M F Scanlon; M Pourmand; A M McGregor; M D Rodriguez-Arnao; K Hall; A Gomez-Pan; R Hall
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

4.  Inappropriate growth-hormone (GH) response to thyrotropin-releasing hormone (TRH) occurs infrequently in well-regulated diabetes mellitus.

Authors:  O Giampietro; M Ferdeghini; R Miccoli; G Gregori; G Penno; S Bertoli; R Navalesi
Journal:  Acta Diabetol Lat       Date:  1990 Apr-Jun

5.  Growth hormone response to hpGRF-40 in different forms of growth retardation and endocrine-metabolic diseases.

Authors:  C Pintor; S Loche; R Puggioni; S G Cella; V Locatelli; F Villa; R Corda; E E Müller
Journal:  Eur J Pediatr       Date:  1986-02       Impact factor: 3.183

Review 6.  Hormonal derangements in uremia.

Authors:  G Tolis; D Goltzman; H Guyda; T Mountokalakis
Journal:  J Endocrinol Invest       Date:  1980 Jan-Mar       Impact factor: 4.256

7.  Arginine induced growth hormone (hGH) response and paradoxical hGH secretion stimulated by TRH in diabetes mellitus.

Authors:  G Winkler; L Gerö; T Halmos; A Grósz; G Gefferth; P Varga; G Tamás
Journal:  Acta Diabetol Lat       Date:  1987 Apr-Jun

8.  The paradoxical response of growth hormone (GH) to thyrotropin-releasing hormone (TRH) in constitutionally tall children involves a cholinergic pathway.

Authors:  E Arteaga; P Valenzuelaa; A Cattani; M del Valle
Journal:  J Endocrinol Invest       Date:  1989-09       Impact factor: 4.256

9.  Inhibitory influence of thyrotropin releasing hormone administration on growth hormone response to low doses of growth hormone-releasing hormone in normal man.

Authors:  A Zanoboni; M Gibillini; M R Cucchi; W Zanoboni Muciaccia; C Zanussi
Journal:  J Endocrinol Invest       Date:  1988-06       Impact factor: 4.256

10.  The influence of thyroid disorders on the dopaminergic regulation of prolactin, thyrotropin and growth hormone.

Authors:  P C Eskildsen; C B Kirkegaard
Journal:  J Endocrinol Invest       Date:  1985-10       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.